Market Place
Sourcing Support
What is fondaparinux sodium used for?
06 Apr 2024 //
PRESS RELEASE
Unlocking the Secrets of Fondaparinux: Your Guide to This Powerful Anticoagulant
30 Jun 2023 //
PRESS RELEASE
Enforcement Report - Week of November 2, 2022
02 Nov 2022 //
FDA
Scinopharm Taiwan Generic Fondaparinux Sodium Receives Approval in US
16 Nov 2018 //
FDA
Jiangsu Hengrui’s Generic Fondaparinux Sodium Receives Approval In US
18 May 2018 //
FDA
AuroMedics’ double take: Glass in vials prompts another recall in US
05 Jan 2018 //
IN PHARMATECHNOLOGIST
Aurobindo Pharma’s Generic Fondaparinux Sodium Receives Approval In US
29 Dec 2017 //
FDA
Aurobindo Pharma gets USFDA nod for Fondaparinux Sodium injection
27 Dec 2017 //
ECONOMIC TIMES
CCI clears Abbott-St Jude deal subject to `voluntary remedies`
19 Dec 2016 //
ECONOMIC TIMES
Dr Reddy`s buys IPR for anti-coagulant drug for $17.5 million
19 Nov 2015 //
ECONOMIC TIMES
Dr Reddy`s completes purchase of Fondaparinux
18 Nov 2015 //
BUSINESS STANDARD
Dr Reddy`s Laboratories to buy IP rights of fondaparinux for $17.5 million
26 Sep 2015 //
THE ECONOMIC TIMES
Anticoagulant Linked With Lower Risk of Death Following Heart Attack Compared to Heparin
20 Feb 2015 //
SCIENCE DAILY
Dr Reddy`s Laboratories To Expand Capacity Of Manufacturing Units In Telangana
04 Feb 2015 //
THE ECONOMIC TIMES
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.